Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study

Fig. 3

Distributions of propensity scores in the unmatched and matched groups. The propensity score was calculated for each patient using a multivariable logistic regression model based on the covariates shown in Table S2 (Additional file 3) and Table S3 (Additional file 4). Comparison of variables according to patterns of intravesical BCG treatment: after propensity score matching. One-to-one matching with a caliper width of 0.2 was applied to maintain a large sample size and balance between two groups: Group a vs. Group b (upper panels), Group b vs. Group c (middle panels), and Group a vs. Group c (lower panels)

Back to article page